Showing results (141-150 of 192) with videos related to
Sort By:
Pageof 20
Nature Medicine|October 8, 2024
Prediction of brain metastasis development with DNA methylation signaturesJeffrey A Zuccato, Yasin Mamatjan, Farshad Nassiri, et al.Cancer|October 26, 2018
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastomaStefania Maraka, Morris D Groves, Aaron G Mammoser, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 3, 2013
Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnosticsRashmi Kanagal-Shamanna, Bryce P Portier, Rajesh R Singh, et al.Neuro-Oncology|August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.Neuro-Oncology|December 6, 2013
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshopJason T Huse, Max Wallace, Kenneth D Aldape, et al.Nature|October 20, 2015
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowthLin Zhang, Siyuan Zhang, Jun Yao, et al.Neuro-Oncology|June 4, 2019
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical managementFarshad Nassiri, Yasin Mamatjan, Suganth Suppiah, et al.Neuro-Oncology|February 13, 2010
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomasJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2013
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional classW Caleb Rutledge, Jun Kong, Jingjing Gao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trialMark R Gilbert, Meihua Wang, Kenneth D Aldape, et al.Pageof 20